Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected
CompletedPhase 1NCT01030640
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Subcutaneous administration of tanezumab can result in changes in the number of nerves around the injection site in the thigh.
Study details
- Official title
- A Phase 1, Randomized, Double- Blind (Sponsor-Open), Placebo-Controlled Study To Examine The Density Of Intraepidermal Nerve Fibers After A Single Subcutaneous Administration Of Tanezumab In Healthy Volunteers
- Conditions
- Osteoarthritis Pain
- Chronic Low Back Pain
- Pain Due to Interstitial Cystitis
- Interventions
- Other: placebo
- Biological: tanezumab
- Sponsor
- Pfizer
- Start date
- 2009-12
- Primary completion
- 2010-09
- Sex
- All
- Age range
- from 18 Years to 55 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Healthy subjects only * Female subjects can not be pregnant or be nursing. * Females and males need to use two types of birth control methods during the length of the study and one of the two methods needs to be a barrier method. * Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Exclusion Criteria: * Subject can not have any chronic or acute medical condition or have had any chronic illness in the past * Can not have any problematic skin condition. * Females can not have more than 7 alcoholic drinks per week and males can not have more than 14 alcoholic drinks per week
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01030640